# Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol

> **NCT07180472** · PHASE4 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Chengdu Medical College** · enrollment: 632 (estimated)

## Conditions studied

- Cerebral Small Vessel Disease

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT07180472
- **Lead sponsor:** First Affiliated Hospital of Chengdu Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-20
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 632 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180472, "Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07180472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*